Managing Partner of Retinal Consultants of Arizona, Founding Member of the Spectra Eye Institute and Clinical Professor at the Department of Ophthalmology at the Keck School of Medicine, University of Southern California. Globally recognized as a clinical researcher, having served as Principal Investigator for over 100 multicenter clinical trials for emerging and FDA-approved therapies for wet age-related macular
degeneration including Beovu®, Lucentis® and Eylea®. Dr. Dugel has authored more than 200 papers and 35 book chapters. He is on the Editorial Board of several major medical journals.